Doug DiRuggiero discusses oral JAK inhibitors for patients with atopic dermatitis and how these new agents will benefit patients with AD.

Dr. Rosen discusses notable papers that he reviewed in his Maui Derm NP+PA Fall Literature Review presentation.
PLAY